Jul. 2 at 9:24 PM
$CCXI $OKLO $ASTS $BRUN
CCXI/AGILITY ROBOTICS, some traders avoiding it due to not having enough revenue. How about ASTS, OKLO and BRUN. Prior to their Spac Merger same issue. No revenue except for BRUN.
Key Bull Case Elements:
• First-Mover Advantage in Commercial Humanoid Deployments: Agility’s Digit robot (and upcoming Digit v5) is already in real-world paid use for warehouse/logistics tasks (e.g., tote handling) with customers like GXO, Schaeffler, Toyota, and Mercado Libre. It has accumulated significant operating hours and data for iterative improvements. Unlike many competitors still in pilot/R&D stages (e.g., Tesla Optimus), Agility has proven deployments, revenue-generating work, and a growing pipeline of 30+ customers. 
• Strong Commercial Momentum and Backlog: Over
$300 million in multi-year contracted orders for Digit v5 (mostly RaaS/subscription model for recurring revenue via hardware, software, maintenance, and cloud platform Agility Arc). This provides visibility and de-risks scaling. RaaS offers predictable revenue with short customer ROI periods (often <2 years vs. human labor costs).

• Massive Addressable Market and Tailwinds: Humanoid robotics targets labor shortages in warehouses, manufacturing, and logistics (repetitive, physically demanding roles). Market projections vary widely but point to strong growth (e.g., from ~
$3B to
$38B+ by 2035 in some forecasts). Broader embodied AI/physical automation could be multi-trillion long-term. Trends like reshoring, aging workforces, and AI advances (partnerships with Nvidia, AWS, etc.) support acceleration. 
• Manufacturing Scale and Cost Roadmap: RoboFab factory in Salem, OR, targeting up to 10,000 units/year at full capacity. Path to reduce bill-of-materials costs significantly (e.g., toward
$30K target). Newer Digit v5 improves dexterity, safety (cooperatively safe AI-enabled), and capabilities for broader tasks. 
• Capital Infusion and Backing: Merger brings >
$620M gross proceeds (~
$420M from SPAC trust + ~
$200M PIPE at
$10/share led by Foxconn, with institutional support). Existing backers include Amazon Industrial Innovation Fund, Nvidia, etc. Strong sponsor/investor alignment (e.g., sponsor stake, low redemptions push). This funds scaling, R&D, and deployments. 
• Valuation and Upside Potential:
$2.5B pre-money valuation positions it as an early pure-play entry. Bull scenarios (aggressive scaling, market leadership, recurring revenue growth) project substantial multiples higher (some optimistic models suggest multi-billion revenue potential and high share price upside by 2030 if execution succeeds). Recent stock surge reflects hype around humanoid AI. 
Risks to note (for balance, though not asked): Early-stage (still unprofitable, high burn), execution on scaling/costs/milestones, competition (Tesla, Figure, Chinese players, etc.), regulatory/tech hurdles, SPAC typical risks (dilution, redemptions), and hype vs. delivery.
In summary, the bull case rests on Agility being the most commercially advanced Western humanoid player at a pivotal time for automation, with real traction, capital, and a path to category leadership in a transformative market.
This makes CCXI a high-risk/high-reward bet on the humanoid robotics wave. Always do your own due diligence; stock prices can be volatile around SPAC deals.
Investors at Agility Robotics: